F. Rosetti

发表

Patients’ Attitudes and Physicians’ Perceptions Toward Maintenance Therapy for Advanced Non–Small‐cell Lung Cancer: A Multicenter Italian Survey

A. Rossi, C. Gridelli, A. Ceribelli, 2017, Clinical Lung Cancer.

Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer

C. Gridelli, V. Adamo, L. Frontini, 2004, British Journal of Cancer.

Brain metastases in breast cancer: Different survival by biological subtype and Ki67 expression.

O. Vinante, S. Olsen, G. Pappagallo, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Five wind partitas : music for the Oettingen Wallerstein Court

F. Rosetti, S. Murray, 1989 .

Seven symphonies from the court of Oettingen-Wallerstein 1773-1795

F. Rosetti, S. Murray, Joseph Fiala, 1985 .

Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials.

C. Gridelli, L. Cavanna, M. Mencoboni, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

A. Rossi, C. Gridelli, D. Galetta, 2003, Journal of the National Cancer Institute.

Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis

M. Mencoboni, A. Addeo, G. Banna, 2018, Clinical and Translational Oncology.

From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).

P. Conte, A. Favaretto, A. Bonetti, 2019, The oncologist.

Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: a meta-analytical approach.

G. Fasola, O. Vinante, M. Aita, 2009, The oncologist.

Hypnosis in the Treatment of Anticipatory Nausea and Vomiting in Patients Receiving Cancer Chemotherapy

G. Azzarello, O. Vinante, G. Pappagallo, 2000, Oncology.

Safety of first trimester exposure to histamine H2 blockers

G. Koren, F. Rosetti, L. Kamboj, 1996, Digestive Diseases and Sciences.

The Impact of Progenitor Enrichment, Serum, and Cytokines on the Ex Vivo Expansion of Mobilized Peripheral Blood Stem Cells: A Controlled Trial

M. Valenti, G. Azzarello, O. Vinante, 2003, Stem cells.

Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS)

E. Zecca, G. Fasola, A. Caraceni, 2016, Advances in Therapy.

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.

S. Barni, R. Labianca, G. Luporini, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A common precursor for the two subunits of the penicillin acylase from Escherichia coli ATCC11105.

P. Santamaria, F. Bolivar, G. Gosset, 1985, Gene.

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial

O. Nanni, D. Amadori, L. Cavanna, 2018, Breast Cancer Research and Treatment.

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials.

A. Rossi, C. Gridelli, L. Cavanna, 2019, Lung cancer.

1207O Bevacizumab + erlotinib vs erlotinib alone as first-line treatment of pts with EGFR mutated advanced non squamous NSCLC: Final analysis of the multicenter, randomized, phase III BEVERLY trial

C. Gridelli, L. Cavanna, L. Crinò, 2021, Annals of Oncology.

Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience

G. Fasola, R. Talamini, U. Tirelli, 2012, BMC Research Notes.

Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience

G. Fasola, R. Talamini, U. Tirelli, 2012, BMC Research Notes.

Addition of bevacizumab to erlotinib as first-line treatment of patients with EGFR-mutated advanced nonsquamous non-small cell lung cancer. The BEVERLY multicenter randomized phase III trial.

C. Gridelli, L. Cavanna, F. de Marinis, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.

A. Rossi, C. Gridelli, A. Ceribelli, 2007, The Lancet. Oncology.

Supportive care in patients with advanced non-small-cell lung cancer

C. Gridelli, L. Frontini, F. Perrone, 2003, British Journal of Cancer.

The impact of a psychological intervention on quality of life in non-metastatic breast cancer.

G. Azzarello, O. Vinante, A. Franchin, 1996, European journal of cancer.

Salvage Therapy with Capecitabine Plus Weekly Paclitaxel in Heavily Pretreated Advanced Breast Cancer

G. Azzarello, O. Vinante, B. Silvestri, 2005 .

The Iconography of Power: From Machiavelli’s Portraits to the Pop Art

F. Rosetti, 2021, Machiavelli in Contemporary Media.

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

A. Rossi, C. Gridelli, D. Galetta, 2003, Journal of the National Cancer Institute.

Efficacy of the addition of cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicenter, randomized phase III MILES-3 and MILES-4 studies.

C. Gridelli, L. Cavanna, F. Ciardiello, 2017 .

Cisplatin in addition to single-agent first-line chemotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC): efficacy results of a joint analysis of the multicentre, randomized phase 3 MILES-3 and MILES-4 studies.

C. Gridelli, L. Cavanna, F. Perrone, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

1365PEffect on quality of life (QOL) of adding cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicentre, randomized, phase 3 MILES-3 and MILES-4 studies

C. Gridelli, L. Cavanna, F. Morgillo, 2017 .